References
D. Verotta and Lewis B. Sheiner. A general conceptual model for non-steady state pharmacokinetic/pharmacodynamic data.J. Pharmacokin. Biopharm. 23: 1–4 (1995).
N. L. Dayneka, V. Garg, and W. J. Jusko. Comparison of four basic models of indirect pharmacodynamic responses.J. Pharmacokin. Biopharm. 21:457–478 (1993).
E. V. Mishina and W. J. Jusko. Inhibition of rat splenocyte proliferation with methylprednisolone: In vivo effect of liposomal formulation.Pharm. Res. 11:848–854 (1994).
A. I. Nichols, F. D. Boudinot, and W. J. Jusko. Second generation model for prednisolone pharmacodynamics in the rat.J. Pharmacokin. Biopharm. 17:209–227 (1989).
w. J. Jusko and H. C. Ko. Physiologic response models characterize diverse types of pharmacodynamic effects.Clin. Pharmacol. Ther. 56:406–419 (1994).
W. F. Ebling, E. N. Lee, and D. R. Stanski. Understanding pharmacokinetics and pharmacodynamics through computer simulation: I. The comparative clinical profiles of fentanyl and alfentanil.Anesthesiology 72:650–658 (1990).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jusko, W.J., Ko, H.C. & Ebling, W.F. Convergence of direct and indirect pharmacodynamic response models. Journal of Pharmacokinetics and Biopharmaceutics 23, 5–8 (1995). https://doi.org/10.1007/BF02353781
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02353781